• Je něco špatně v tomto záznamu ?

In vitro investigation of hyaluronan-based polymeric micelles for drug delivery into the skin: The internalization pathway

J. Starigazdová, K. Nešporová, M. Čepa, R. Šínová, D. Šmejkalová, G. Huerta-Angeles, V. Velebný,

. 2020 ; 143 (-) : 105168. [pub] 20191126

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028496

In our previous research, we concluded that polymeric micelles based on hyaluronic acid are able to penetrate into the deeper layers of skin tissue. The aim of this work was to characterize the mechanisms involved in the uptake by skin cells, which is important for understanding the influence of the carrier composition on the drug penetration. To reach this goal, we used micelles encapsulating curcumin made of oleyl-hyaluronan (HAC18:1) and hexyl-hyaluronan (HAC6) covalently linked with fluorescent Nile Blue. This labeling enabled us to track the micelle-forming derivative and also micelle payload into the keratinocytes and fibroblasts by fluorescent microscopy and flow cytometry. The regulation of both the passive and active cellular uptake was used to determine the mechanism of micelle internalization. Furthermore, the changes of membrane fluidity were measured for these derivatives by FRAP. Using these methods we concluded that carriers entered the cells using both active and passive transport. Passive transport was facilitated by the affinity of the carrier to the cell membrane, especially in the case of HAC18:1 carrier, which changed significantly the membrane fluidity. The active transport was dependent on cell type, but mainly driven by the clathrin-mediated endocytosis and macropinocytosis. Surprisingly, the main HA receptor, CD44, was not involved in the uptake. We can conclude that these carrier systems could be used for the local transport of active substances or hydrophobic drugs into the skin cells using the advantage of passive transport of oleyl-HA derivative.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028496
003      
CZ-PrNML
005      
20210114154041.0
007      
ta
008      
210105s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejps.2019.105168 $2 doi
035    __
$a (PubMed)31783157
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Starigazdová, Jana $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
245    10
$a In vitro investigation of hyaluronan-based polymeric micelles for drug delivery into the skin: The internalization pathway / $c J. Starigazdová, K. Nešporová, M. Čepa, R. Šínová, D. Šmejkalová, G. Huerta-Angeles, V. Velebný,
520    9_
$a In our previous research, we concluded that polymeric micelles based on hyaluronic acid are able to penetrate into the deeper layers of skin tissue. The aim of this work was to characterize the mechanisms involved in the uptake by skin cells, which is important for understanding the influence of the carrier composition on the drug penetration. To reach this goal, we used micelles encapsulating curcumin made of oleyl-hyaluronan (HAC18:1) and hexyl-hyaluronan (HAC6) covalently linked with fluorescent Nile Blue. This labeling enabled us to track the micelle-forming derivative and also micelle payload into the keratinocytes and fibroblasts by fluorescent microscopy and flow cytometry. The regulation of both the passive and active cellular uptake was used to determine the mechanism of micelle internalization. Furthermore, the changes of membrane fluidity were measured for these derivatives by FRAP. Using these methods we concluded that carriers entered the cells using both active and passive transport. Passive transport was facilitated by the affinity of the carrier to the cell membrane, especially in the case of HAC18:1 carrier, which changed significantly the membrane fluidity. The active transport was dependent on cell type, but mainly driven by the clathrin-mediated endocytosis and macropinocytosis. Surprisingly, the main HA receptor, CD44, was not involved in the uptake. We can conclude that these carrier systems could be used for the local transport of active substances or hydrophobic drugs into the skin cells using the advantage of passive transport of oleyl-HA derivative.
650    _2
$a aplikace lokální $7 D000287
650    _2
$a kultivované buňky $7 D002478
650    _2
$a kurkumin $x aplikace a dávkování $7 D003474
650    12
$a lékové transportní systémy $7 D016503
650    _2
$a endocytóza $7 D004705
650    _2
$a fibroblasty $x metabolismus $7 D005347
650    _2
$a lidé $7 D006801
650    _2
$a kyselina hyaluronová $x aplikace a dávkování $7 D006820
650    _2
$a keratinocyty $x metabolismus $7 D015603
650    _2
$a lyzozomy $x metabolismus $7 D008247
650    _2
$a polymery $x aplikace a dávkování $7 D011108
650    _2
$a kůže $x metabolismus $7 D012867
650    12
$a kožní absorpce $7 D012869
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nešporová, Kristina $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic. Electronic address: kristina.nesporova@contipro.com.
700    1_
$a Čepa, Martin $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Šínová, Romana $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic; Department of Experimental Biology, Faculty of Sciences, Masaryk University, Kotlářská 267/2, 611 37 Brno, Czech Republic.
700    1_
$a Šmejkalová, Daniela $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Huerta-Angeles, Gloria $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
700    1_
$a Velebný, Vladimír $u Contipro a.s., Dolní Dobrouč 401, 561 02 Dolní Dobrouč, Czech Republic.
773    0_
$w MED00001639 $t European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 143, č. - (2020), s. 105168
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31783157 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154038 $b ABA008
999    __
$a ok $b bmc $g 1608831 $s 1119676
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 143 $c - $d 105168 $e 20191126 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace